IFN-γ licenses CD11b+ cells to induce progression of systemic lupus erythematosus

Wiik, 2003, Autoantibodies in vasculitis, Arthritis Res. Ther., 5, 147, 10.1186/ar758 Baslund, 1994, Anti-neutrophil cytoplasmic autoantibodies (ANCA) and vasculitis, Clin. Rev. Allergy, 12, 297, 10.1007/BF02802324 Lipsky, 2001, Systemic lupus erythematosus: an autoimmune disease of B cell hyperactivity, Nat. Immunol., 2, 764, 10.1038/ni0901-764 Eggert, 2010, Autoantibodies in autoimmune diseases, Curr. Pharm. Des., 16, 1634, 10.2174/138161210791164144 Bogdanos, 2009, Autoantibodies and their antigens in autoimmune hepatitis, Semin. Liver Dis., 29, 241, 10.1055/s-0029-1233533 Lee, 2006, 4. Autoimmunity, vasculitis, and autoantibodies, J. Allergy Clin. Immunol., 117, S445, 10.1016/j.jaci.2005.06.023 Tsokos, 2011, Systemic lupus erythematosus, N. Engl. J. Med., 365, 2110, 10.1056/NEJMra1100359 Preble, 1982, Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon, Science, 216, 429, 10.1126/science.6176024 Nagata, 2010, Autoimmunity and the clearance of dead cells, Cell, 140, 619, 10.1016/j.cell.2010.02.014 Rumore, 1990, Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone, J. Clin. Invest., 86, 69, 10.1172/JCI114716 McGaha, 2005, Restoration of tolerance in lupus by targeted inhibitory receptor expression, Sci. (New York, N. Y. ), 307, 590, 10.1126/science.1105160 Paunovic, 2012, Immune complex-mediated co-ligation of the BCR with FcgammaRIIB results in homeostatic apoptosis of B cells involving Fas signalling that is defective in the MRL/Lpr model of systemic lupus erythematosus, J. Autoimmun., 39, 332, 10.1016/j.jaut.2012.04.006 Nimmerjahn, 2008, Fcgamma receptors as regulators of immune responses, Nat. Rev. Immunol., 8, 34, 10.1038/nri2206 Kyogoku, 2002, Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility, Arthritis Rheum., 46, 1242, 10.1002/art.10257 Arbuckle, 2003, Development of autoantibodies before the clinical onset of systemic lupus erythematosus, N. Engl. J. Med., 349, 1526, 10.1056/NEJMoa021933 Bennett, 2003, Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J. Exp. Med., 197, 711, 10.1084/jem.20021553 Marshak-Rothstein, 2006, Toll-like receptors in systemic autoimmune disease, Nat. Rev. Immunol., 6, 823, 10.1038/nri1957 Gota, 2003, Induction of clinical autoimmune disease by therapeutic interferon-alpha, Autoimmunity, 36, 511, 10.1080/08916930310001605873 Santiago-Raber, 2003, Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice, J. Exp. Med., 197, 777, 10.1084/jem.20021996 Christensen, 2006, Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus, Immunity, 25, 417, 10.1016/j.immuni.2006.07.013 Schroder, 2004, Interferon-gamma: an overview of signals, mechanisms and functions, J. Leukoc. Biol., 75, 163, 10.1189/jlb.0603252 Hervas-Stubbs, 2011, Direct effects of type I interferons on cells of the immune system, Clin. Cancer Res., 17, 2619, 10.1158/1078-0432.CCR-10-1114 Boehm, 1997, Cellular responses to interferon-gamma, Annu. Rev. Immunol., 15, 749, 10.1146/annurev.immunol.15.1.749 Zhang, 1998, Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15, Immunity, 8, 591, 10.1016/S1074-7613(00)80564-6 Montoya, 2002, Type I interferons produced by dendritic cells promote their phenotypic and functional activation, Blood, 99, 3263, 10.1182/blood.V99.9.3263 Rahman, 2008, Systemic lupus erythematosus, N. Engl. J. Med., 358, 929, 10.1056/NEJMra071297 Willcocks, 2010, A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus, Proc. Natl. Acad. Sci. U S A, 107, 7881, 10.1073/pnas.0915133107 Fukuyama, 2005, The inhibitory Fcgamma receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells, Nat. Immunol., 6, 99, 10.1038/ni1151 Leiss, 2013, Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation, Lupus, 22, 778, 10.1177/0961203313492869 Lang, 2010, Genes determining the course of virus persistence in the liver: lessons from murine infection with lymphocytic choriomeningitis virus, Cell. Physiol. Biochem., 26, 263, 10.1159/000320549 Kagi, 1996, Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo, Annu. Rev. Immunol., 14, 207, 10.1146/annurev.immunol.14.1.207 Zinkernagel, 2002, Lymphocytic choriomeningitis virus and immunology, Curr. Top. Microbiol. Immunol., 263, 1 Thale, 2005, Sources of interferon-gamma (IFN-gamma) in early immune response to Listeria monocytogenes, Immunobiology, 210, 673, 10.1016/j.imbio.2005.07.003 Lang, 2008, Aggravation of viral hepatitis by platelet-derived serotonin, Nat. Med., 14, 756, 10.1038/nm1780 Recher, 2007, Extralymphatic virus sanctuaries as a consequence of potent T-cell activation, Nat. Med., 13, 1316, 10.1038/nm1670 Radeke, 2002, Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis, J. Biol. Chem., 277, 27535, 10.1074/jbc.M200419200 Joller, 2010, Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting, Proc. Natl. Acad. Sci. U S A, 107, 20441, 10.1073/pnas.1013827107 Toussirot, 2008, Epstein-Barr virus in autoimmune diseases, Best. Pract. Res. Clin. Rheumatol., 22, 883, 10.1016/j.berh.2008.09.007 Harley, 2006, Epstein-Barr virus infection induces lupus autoimmunity, Bull. NYU Hosp. Jt. Dis., 64, 45 Ramos-Casals, 2005, Antimitochondrial antibodies in patients with chronic hepatitis C virus infection: description of 18 cases and review of the literature, J. Viral Hepat., 12, 648, 10.1111/j.1365-2893.2005.00642.x Ijichi, 1999, Human T-cell lymphotropic virus type I and systemic lupus erythematosus, Intern. Med., 38, 459, 10.2169/internalmedicine.38.459 Morgan, 1977, Measles virus and its associated diseases, Bacteriol. Rev., 41, 636, 10.1128/MMBR.41.3.636-666.1977 Gyorkey, 1969, Systemic lupus erythematosus and myxovirus, N. Engl. J. Med., 280, 333, 10.1056/NEJM196902062800620 Ziff, 1971, Viruses and the connective tissue diseases, Ann. Intern. Med., 75, 951, 10.7326/0003-4819-75-6-951 Christian, 1973, Viruses and autoimmunity, Am. J. Med., 54, 611, 10.1016/0002-9343(73)90119-8 Perl, 2010, Endogenous retroviral pathogenesis in lupus, Curr. Opin. Rheumatol., 22, 483, 10.1097/BOR.0b013e32833c6297 Agmon-Levin, 2009, Molecular mimicry in systemic lupus erythematosus, Lupus, 18, 1181, 10.1177/0961203309346653 Kaplan, 2011, Neutrophils in the pathogenesis and manifestations of SLE, Nat. Rev. Rheumatol., 7, 691, 10.1038/nrrheum.2011.132 Villanueva, 2011, Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus, J. Immunol., 187, 538, 10.4049/jimmunol.1100450 Carmona-Rivera, 2013, Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity, Semin. Immunopathol., 35, 455, 10.1007/s00281-013-0375-7 Ren, 2003, Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus, Arthritis Rheum., 48, 2888, 10.1002/art.11237 Lieberman, 2010, The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity, J. Biomed. Biotechnol., 10.1155/2010/740619 Wigfall, 1988, Interleukin-2 receptor expression in peripheral blood lymphocytes from systemic lupus erythematosus patients: relationship to clinical activity, Clin. Immunol. Immunopathol., 47, 354, 10.1016/S0090-1229(88)80012-6 Blanco, 2005, Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus, Arthritis Rheum., 52, 201, 10.1002/art.20745 Dolff, 2013, Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis, Arthritis Res. Ther., 15, R36, 10.1186/ar4189 Dolff, 2010, Urinary T cells in active lupus nephritis show an effector memory phenotype, Ann. Rheum. Dis., 69, 2034, 10.1136/ard.2009.124636 Recher, 2004, Deliberate removal of T cell help improves virus-neutralizing antibody production, Nat. Immunol., 5, 934, 10.1038/ni1102 Lang, 2006, Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling, J. Clin. Invest., 116, 2456, 10.1172/JCI28349 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 40, 1725, 10.1002/art.1780400928